Company Delivers Another Record Quarter, Beating Average Consensus by 20% ~ ~ Marks 11 Consecutive Quarters of Strong ...
Pending acquisition of Calavo Growers progressing; expected to close in the fiscal third quarterOXNARD, Calif., March 12, ...
Good morning, everybody, and welcome to our Annual Media Conference of the Volkswagen Group at Wolfsburg, and it's great to have you here today. And for those of you who are joining us online, welcome ...
A Coma Pattern-Based Autofocusing Method Resolves Bacterial Cold Shock Response at Single-Cell Level
Imaging-based single-cell physiological profiling holds great potential for uncovering fundamental bacterial cold shock response (CSR) mechanisms, but its application is impeded by severe focus drift ...
President Donald J. Trump oversees Operation Epic Fury at Mar-a-Lago, Palm Beach, FL, Feb. 28, 2026. (White House photo by Daniel Torok) We have become spectators in the demolition of an era. We are ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
The session's defining paradox — the one that makes Wednesday analytically significant rather than just directionally negative — is that the IEA announced the largest emergency oil reserve release in ...
TORONTO, March 6, 2026 /CNW/ - Starlight Western Canada Multi-Family (No. 2) Fund (the "Fund") announced today its results of operations and financial condition for the three months ended December 31, ...
YCANTH® net revenue grew 130% to $15.3 million in 2025, and selling, general and administrative expenses decreased by over 40 ...
YCANTH® net revenue grew 130% to $15.3 million in 2025, and selling, general and administrative expenses decreased by over 40%, when compared to 2024 - - Company earned $35.6 million in total revenue ...
Detailed price information for California Water Service Group Holding (CWT-N) from The Globe and Mail including charting and trades.
Detailed price information for Spyre Therapeutics Inc (SYRE-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results